Get the Stockscreener App
136.01
0.37%
0.50
After Hours:
136.01
Overview
News
Price History
Option Chain
Financials
Why A Down?
Discussions
Forecast
Stock Split
Dividend History
Agilent Technologies Inc stock is traded at $136.01, with a volume of 3.13M.
It is up +0.37% in the last 24 hours and up +18.19% over the past month.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
See More
Previous Close:
$135.51
Open:
$135.17
24h Volume:
3.13M
Relative Volume:
1.44
Market Cap:
$38.41B
Revenue:
$7.23B
Net Income/Loss:
$1.41B
P/E Ratio:
27.32
EPS:
4.979
Net Cash Flow:
$1.09B
1W Performance:
+7.04%
1M Performance:
+18.19%
6M Performance:
-1.72%
1Y Performance:
+13.89%
1-Day Range:
$134.98
$137.50
1-Week Range:
$125.57
$138.62
52-Week Range:
$108.35
$160.27
Agilent Technologies Inc Stock (A) Company Profile
Name
Agilent Technologies Inc
Sector
Industry
Phone
(408) 345-8886
Address
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Compare A vs TMO, DHR, IDXX, NTRA
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
A
Agilent Technologies Inc
|
136.01 | 38.27B | 7.23B | 1.41B | 1.09B | 4.979 |
TMO
Thermo Fisher Scientific Inc
|
513.03 | 187.95B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
196.19 | 136.75B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
551.50 | 43.78B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
261.91 | 37.34B | 2.50B | -226.32M | 71.51M | -1.6412 |
Agilent Technologies Inc Stock (A) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-20-26 | Initiated | HSBC Securities | Buy |
| Jan-05-26 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-15-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-09-25 | Initiated | Goldman | Buy |
| Dec-02-25 | Initiated | Morgan Stanley | Overweight |
| Oct-08-25 | Initiated | Rothschild & Co Redburn | Buy |
| Oct-08-25 | Upgrade | UBS | Neutral → Buy |
| Feb-10-25 | Upgrade | Barclays | Underweight → Equal Weight |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jul-10-24 | Upgrade | Citigroup | Neutral → Buy |
| Jun-27-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Apr-05-24 | Upgrade | Stifel | Hold → Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Dec-12-23 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-17-23 | Downgrade | UBS | Buy → Neutral |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-31-23 | Downgrade | Evercore ISI | Outperform → In-line |
| May-24-23 | Reiterated | Barclays | Equal Weight |
| May-24-23 | Reiterated | BofA Securities | Buy |
| May-24-23 | Reiterated | Citigroup | Neutral |
| May-24-23 | Reiterated | Credit Suisse | Outperform |
| May-24-23 | Reiterated | Evercore ISI | Outperform |
| May-24-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| May-24-23 | Reiterated | Robert W. Baird | Outperform |
| May-24-23 | Reiterated | SVB Securities | Outperform |
| May-24-23 | Reiterated | Stifel | Hold |
| May-24-23 | Reiterated | TD Cowen | Outperform |
| May-24-23 | Reiterated | Wells Fargo | Overweight |
| May-11-23 | Initiated | Barclays | Equal Weight |
| Jan-10-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jul-20-22 | Initiated | UBS | Buy |
| Jul-08-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-23-22 | Reiterated | BofA Securities | Buy |
| Feb-23-22 | Reiterated | Citigroup | Buy |
| Feb-23-22 | Reiterated | Cowen | Outperform |
| Feb-23-22 | Reiterated | Evercore ISI | Outperform |
| Feb-23-22 | Reiterated | Stifel | Hold |
| Feb-23-22 | Reiterated | Wells Fargo | Overweight |
| Nov-23-21 | Reiterated | BofA Securities | Buy |
| Nov-23-21 | Reiterated | Cowen | Outperform |
| Nov-23-21 | Reiterated | Stifel | Hold |
| Mar-18-21 | Upgrade | Citigroup | Neutral → Buy |
| Feb-17-21 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-02-20 | Initiated | Goldman | Buy |
| Nov-25-20 | Upgrade | UBS | Neutral → Buy |
| Nov-17-20 | Upgrade | Cleveland Research | Neutral → Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-30-20 | Initiated | Atlantic Equities | Neutral |
| Aug-19-20 | Reiterated | BofA Securities | Neutral |
| Aug-19-20 | Reiterated | Citigroup | Neutral |
| Aug-19-20 | Reiterated | Jefferies | Buy |
| Aug-19-20 | Reiterated | Robert W. Baird | Outperform |
| Aug-19-20 | Reiterated | SVB Leerink | Outperform |
| Aug-19-20 | Reiterated | Stifel | Hold |
| Aug-19-20 | Reiterated | Wells Fargo | Overweight |
| Feb-24-20 | Downgrade | Needham | Buy → Hold |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Neutral |
| Nov-26-19 | Reiterated | Needham | Buy |
| Nov-15-19 | Initiated | Stifel | Hold |
| Oct-18-19 | Downgrade | UBS | Buy → Neutral |
| Jul-16-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jul-15-19 | Downgrade | Barclays | Overweight → Equal Weight |
View All
Agilent Technologies Inc Stock (A) Latest News
Agilent Technologies, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 1/2 Sh - TradingView
Why Is Agilent (A) Up 0.1% Since Last Earnings Report? - Yahoo Finance
Laboratory Information Management Systems (LIMS) Market Size Expected to Reach USD 5.19 Billion by 2030 | MarketsandMarkets™ - GlobeNewswire Inc.
Is Agilent Technologies (NYSE:A) Still A Reliable Dividend Story? - Kalkine Media
Agilent finalizes Biocare Medical takeover - MedTech Dive
Agilent 8890 GC System from Agilent Technologies Inc.flexible chromatograph for demanding labs - Ad-hoc-news.de
Bernstein SocGen resumes Agilent stock coverage with outperform rating - Investing.com
Agilent (A) Receives Outperform Rating with $155 Price Target - GuruFocus
Bernstein SocGen resumes Agilent stock coverage with outperform rating By Investing.com - Investing.com Canada
Agilent Technologies, Inc. (NYSE:A) Passed Our Checks, And It's About To Pay A US$0.255 Dividend - simplywall.st
Agilent Technologies completes Biocare deal, shares react to healthcare expansion - Ad-hoc-news.de
Agilent Technologies Closes $600 Million 4.900% Senior Notes Due 2032 Offering and Registration Rights Agreement - Minichart
The 6495D Triple Quadrupole LC/MS from Agilent Technologies Inc.ultra-low detection limits for de - Ad-hoc-news.de
Agilent Technologies, Inc. Actuals & Estimates (BIVA:A) - TradingView
Agilent Technologies (A) Announces $600 Million Senior Notes Off - GuruFocus
Agilent (A) Stock Trades Up, Here Is Why - Yahoo Finance
Agilent Technologies, Inc. Actuals & Estimates (EUROTLX:4A) - TradingView
Agilent Sells $600 Million of 4.900% Senior Notes Due 2032 in Private Offering - TradingView
Agilent (NYSE: A) issues $600M 4.900% senior notes maturing in 2032 - Stock Titan
Agilent Technologies, Inc. (NYSE:A) completed the acquisition of Biocare Medical, LLC from an investor group led by Excellere Capital Fund III LP, a fund managed by Excellere Capital Management LLC and GHO Capital Partners LLP. - marketscreener.com
Agilent Technologies earnings outlook steady, shares tracked on NYSE - Ad-hoc-news.de
Agilent completes acquisition of Biocare Medical - Investing.com UK
Agilent completes $950 million Biocare acquisition - grafa.com
Agilent Completes Acquisition of Biocare Medical - Contract Pharma
Agilent Technologies lifts guidance, shares extend recent NYSE gains - Ad-hoc-news.de
Agilent (A) Finalizes Acquisition of Biocare Medical - GuruFocus
Agilent Completes Biocare Medical Acquisition to Expand Pathology Diagnostics Portfolio - citybiz
Agilent: Acquisition Expected to Be Accretive to Top-Line Growth Rate, Margin Profile and Non-Instrument Rev Mix in the First Yr >A - Moomoo
Agilent Technologies, Inc. (A) Initiated at Neutral With $150 Price Target by Piper Sandler - Insider Monkey
Agilent Technologies Completes Purchase of Biocare Medical From Excellere-Led Investor Group - marketscreener.com
Agilent completes acquisition of Biocare Medical By Investing.com - Investing.com Canada
Excellere Partners and GHO Capital complete sale of Biocare Medical to Agilent Technologies - The Manila Times
A6433334 Bond Price and Chart — FINRA:A6433334 - TradingView
A Look at Agilent Technologies Inc (A) After 3.9% Gain -- GF Val - GuruFocus
Agilent Technologies Inc (A)'s Winning Formula: Financial Metrics and Competitive Strengths - GuruFocus
Agilent Technologies Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Is the options market predicting a spike in Agilent Technologies stock? - MSN
Agilent Technologies lifts full-year guidance, shares react to Ignite strategy - Ad-hoc-news.de
How Agilent’s Upgraded Outlook and Cancer Diagnostics Push Could Impact Agilent Technologies (A) Investors - Sahm
Agilent Technologies Inc (A) Institutional Confidence - TradingKey
Form 8K Agilent Technologies For: 23 June By Investing.com - Investing.com South Africa
Form 6K Agilent Technologies For: 23 June By Investing.com - Investing.com Canada
Barclays Adjusts Price Target on Agilent Technologies to $150 From $145, Maintains Overweight Rating - Moomoo
Agilent Technologies options draw attention, analysts keep a cautious stance on the shares - AD HOC NEWS
Agilent Technologies Inc (A) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Why Agilent Stock Is Slipping Premarket Today - Stocktwits
The InfinityLab LC Series 1260 Infinity II from Agilent Technologies Inc.mid-range HPLC workhorse - AD HOC NEWS
Is the Options Market Predicting a Spike in Agilent Technologies Stock? - Yahoo Finance
Agilent Technologies, Inc. (A) Stock Analysis: A 26.2% Upside Beckons in the Diagnostics & Research Arena - DirectorsTalk Interviews
Agilent Technologies StockAnalyst views after recent earnings beat - AD HOC NEWS
Agilent Technologies (A) Stock Could Be 23% Undervalued After Earnings Beat And Guidance Raise - Yahoo Finance
Agilent Technologies Inc Stock (A) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
0.66%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):